New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
Serum gastrin levels are associated with prevalent neuroendocrine tumors in autoimmune metaplastic atrophic gastritis.
ÌÇÐÄ´«Ã½
Serum gastrin levels are associated with prevalent neuroendocrine tumors in autoimmune metaplastic atrophic gastritis. The American journal of gastroenterology Jove, A., Lin, C., Hwang, J. H., Vidhya, B., Fernandez-Becker, N. Q., Huang, R. J. 2024Abstract
Autoimmune metaplastic atrophic gastritis (AMAG) is a precancerous condition that predisposes to gastric neuroendocrine tumors (gNET). There exist no methods to stratify AMAG patients for gNET risk.We identified a cohort of patients with AMAG within a university health system using histopathologic and serologic criteria. We analyzed features predictive of prevalent gNET.We identified 181 AMAG patients, 41 (22.7%) with prevalent gNET. Gastrin levels were elevated in gNET (1859.8 versus 679.5 pg/mL, p<0.001), and gastrin titers demonstrated good discrimination (c=0.799, 95% CI 0.707-0.892) for gNET.Gastrin levels differ significantly between AMAG patients with and without gNET.
View details for
View details for